D'ORSI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 237
AS - Asia 57
NA - Nord America 30
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 328
Nazione #
IT - Italia 228
US - Stati Uniti d'America 28
SG - Singapore 22
CN - Cina 19
VN - Vietnam 9
GB - Regno Unito 2
HK - Hong Kong 2
ID - Indonesia 2
IN - India 2
AU - Australia 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
DE - Germania 1
FR - Francia 1
HR - Croazia 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
RU - Federazione Russa 1
UA - Ucraina 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 328
Città #
Genoa 164
Vado Ligure 39
Rapallo 21
San Jose 12
Singapore 9
Ho Chi Minh City 4
Tianjin 4
Beijing 2
Bordighera 2
Haiphong 2
Hong Kong 2
London 2
Thái Bình 2
Albuquerque 1
Amsterdam 1
Angra dos Reis 1
Atlanta 1
Bandung 1
Banyuwangi 1
Brandon 1
Buffalo 1
Cairo 1
Cape Town 1
Chehalis 1
Council Bluffs 1
Frankfurt am Main 1
Hanoi 1
Lauterbourg 1
Los Angeles 1
Manning 1
Mexico City 1
Naples 1
Rome 1
San Rafael de Onoto 1
Santa Clara 1
Sydney 1
Tokyo 1
Udaipur 1
Ulan-Ude 1
Virginia Beach 1
Zagreb 1
Zurich 1
Totale 294
Nome #
Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF) 109
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 88
Corrigendum to “Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)” Seminars in Arthritis and Rheumatism 55 (2022) 152024 (Seminars in Arthritis and Rheumatism (2022) 55, (S0049017222000750), (10.1016/j.semarthrit.2022.152024)) 73
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 68
Totale 338
Categoria #
all - tutte 1.234
article - articoli 994
book - libri 0
conference - conferenze 240
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202325 0 3 0 5 2 0 0 2 6 1 6 0
2023/202442 0 2 3 4 2 9 5 3 1 3 5 5
2024/2025120 7 7 9 3 7 14 9 29 3 9 14 9
2025/2026151 25 5 8 16 27 9 23 8 12 18 0 0
Totale 338